Abstract:Objective: Multiple Sclerosis (MS) is an autoimmune disorder characterized by demyelination occurring within the white matter of the central nervous system. While its pathogenesis is intricately linked with the body's immune response, the precise underlying mechanisms remain elusive. This study aims to explore potential immune-related genes associated with MS and assess the causal relationship between these genes and the risk of developing MS. Methods: We retrieved expression datasets of peripheral blood mononuclear cells from MS patients from the Gene Expression Omnibus (GEO) database. Immune-related differentially expressed genes (IM-DEGs) were identified using the ImmPort database. GO and KEGG analyses were subsequently performed to elucidate the functions and pathways associated with the IM-DEGs. To visualize protein–protein interactions (PPIs), we used STRING, Cytoscape, and Cytohubba to construct networks of PPIs and hub genes. The diagnostic efficacy of hub genes was assessed using the nomogram model and ROC curve. The correlation of these hub genes was further validated in the mouse EAE model using quantitative PCR (qPCR). Finally, Mendelian randomization (MR) was performed to ascertain the causal impact of hub genes on MS. Results: Twenty-eight IM-DEGs were selected from the intersection of DEGs and immune genes. These genes are involved mainly in antigen receptor-mediated signaling pathways, B cell differentiation, B cell proliferation, and B cell receptor signaling pathways. Using Cytoscape software for analysis, the top 10 genes with the highest scores were identified as PTPRC, CD19, CXCL8, CD79A, IL7, CR2, CD22, BLNK, LCN2, and LTF. Five hub genes (PTPRC, CD19, CXCL8, CD79A, and IL7) are considered to have strong diagnostic potential. In the qPCR validation, the relative expression of these five genes showed significant differences between the control and EAE groups, indicating that these genes may play a potential role in the pathogenesis of MS. The MR results indicate that elevated levels of CD79A (OR = 1.106, 95% CI 1.002–1.222, p = 0.046) are causally positively associated with the risk of developing MS. Conclusion: This study integrated GEO data mining with MR to pinpoint pivotal immune genes linked to the onset of MS, thereby offering novel strategies for the treatment of MS.

MSGD: a manually curated database of genomic, transcriptomic, proteomic and drug information for multiple sclerosis

MyBASE: a Database for Genome Polymorphism and Gene Function Studies of Mycobacterium

Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis

MSdb: An integrated expression atlas of human musculoskeletal system

Integration of Genetic and Immune Infiltration Insights into Data Mining of Multiple Sclerosis Pathogenesis

Combining gene expression microarrays and Mendelian randomization: exploring key immune-related genes in multiple sclerosis

Network-Based Target Prioritization and Drug Candidate Identification for Multiple Sclerosis: from Analyzing "omics Data" to Druggability Simulations.

Multiple Sclerosis Stages and their Differentially Expressed Genes: A Bioinformatics Analysis

Relationship between gut microbiota and multiple sclerosis: a scientometric visual analysis from 2010 to 2023

Quantitative proteomics and multi-omics analysis identifies potential biomarkers and the underlying pathological molecular networks in Chinese patients with multiple sclerosis

Knowledge mapping of disease-modifying therapy (DMT) in multiple sclerosis (MS): A bibliometrics analysis

Multi-omics integration prioritizes potential drug targets for multiple sclerosis

MSMK: Multiscale Module Kernel for Identifying Disease-Related Genes

Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study

GMMID: genetically modified mice information database

ggmsa: a visual exploration tool for multiple sequence alignment and associated data

Bioinformatics analysis of the potential biomarkers of Multiple Sclerosis and Guillain-Barre syndrome

Mining gene expression data of multiple sclerosis

Gene-Based Tests of a Genome-Wide Association Study Dataset Highlight Novel Multiple Sclerosis Risk Genes

Imgmd: A Platform for the Integration and Standardisation of in Silico Microbial Genome-Scale Metabolic Models

Bioinformatics analysis of the potential biomarkers of Multiple Sclerosis and Guillain-Barré syndrome